Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis

BACKGROUND: Non-small cell lung cancer (NSCLC) has a poor prognosis despite conventional treatments of surgery, radiotherapy, and chemotherapy. Small-molecule tyrosine kinase inhibitors acting on epidermal growth factor receptor (EGFR) have shown high efficacy and low toxicity for NSCLC. In particul...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Zhou, Kenan, Zhao, Shishun, Guo, Wenlai, Ding, Lei
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2020
Fag:
6700
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7220199/
https://ncbi.nlm.nih.gov/pubmed/32011468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000018771
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker